Glucocorticoid receptor binding: A biphasic dependence on molecular size as revealed by the bilinear LinBiExp model

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

For corticosteroids, receptor-binding affinity (RBA) at the glucocorticoid receptor (GR) is a major determinant of therapeutic potential. Here, the results of a comprehensive quantitative analysis of relative RBA (rRBA) data obtained from more than a hundred active structures are reported. Because of a clear biphasic size-dependence, the recently introduced linearized biexponential (LinBiExp) model provided very good fit: for steroids that satisfy the main binding criteria at the GR, it accounts for close to 80% of the variability in the free energy of binding ΔG0 (or log rRBA) data by using only two descriptors: calculated molecular volume and an indicator variable for the presence of 6α/9α-halogen or cyclic 16,17-acetal moieties. Accordingly, binding is strongest for corticosteroids close to an ideal size that is large enough to provide as large nonspecific (van der Waals-type) interactions as possible, but is not too large to have difficulty fitting due to size-limitations at the binding site. Binding affinity is dramatically increased by 6α- or 9α-halogenation or introduction of a cyclic 16,17-acetal moiety (in average, about 7-fold), but there is no significant increase after the first substitution. Known highly active glucocorticoids, such as betamethasone 17-monopropionate, fluticasone propionate, or mometasone furoate, indeed satisfy both of these criteria. For small-enough structures, the obtained size-dependency (slope) of the free energy of binding suggest that, as long as only nonspecific interactions are involved, addition of a methylene-sized non-hydrogen atom to the ligand structure increases ΔG0 on average by about 1.5 kJ/mol, corresponding to an almost doubling of the binding affinity.

Original languageEnglish
Pages (from-to)193-208
Number of pages16
JournalSteroids
Volume73
Issue number2
DOIs
StatePublished - Feb 1 2008

Fingerprint

Acetals
Mometasone Furoate
Glucocorticoid Receptors
Free energy
Halogenation
Halogens
Steroid Receptors
Glucocorticoids
Adrenal Cortex Hormones
Substitution reactions
Steroids
Binding Sites
Ligands
Atoms
Chemical analysis
Therapeutics
Fluticasone
betamethasone 17-monopropionate
fluticasone furoate

Keywords

  • Binding affinity
  • Fluorination
  • Glucocorticoid
  • Molecular size
  • Structure-activity relationship

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Molecular Biology

Cite this

Glucocorticoid receptor binding : A biphasic dependence on molecular size as revealed by the bilinear LinBiExp model. / Buchwald, Peter.

In: Steroids, Vol. 73, No. 2, 01.02.2008, p. 193-208.

Research output: Contribution to journalArticle

@article{1551345230b44543bb78e685dabc834d,
title = "Glucocorticoid receptor binding: A biphasic dependence on molecular size as revealed by the bilinear LinBiExp model",
abstract = "For corticosteroids, receptor-binding affinity (RBA) at the glucocorticoid receptor (GR) is a major determinant of therapeutic potential. Here, the results of a comprehensive quantitative analysis of relative RBA (rRBA) data obtained from more than a hundred active structures are reported. Because of a clear biphasic size-dependence, the recently introduced linearized biexponential (LinBiExp) model provided very good fit: for steroids that satisfy the main binding criteria at the GR, it accounts for close to 80{\%} of the variability in the free energy of binding ΔG0 (or log rRBA) data by using only two descriptors: calculated molecular volume and an indicator variable for the presence of 6α/9α-halogen or cyclic 16,17-acetal moieties. Accordingly, binding is strongest for corticosteroids close to an ideal size that is large enough to provide as large nonspecific (van der Waals-type) interactions as possible, but is not too large to have difficulty fitting due to size-limitations at the binding site. Binding affinity is dramatically increased by 6α- or 9α-halogenation or introduction of a cyclic 16,17-acetal moiety (in average, about 7-fold), but there is no significant increase after the first substitution. Known highly active glucocorticoids, such as betamethasone 17-monopropionate, fluticasone propionate, or mometasone furoate, indeed satisfy both of these criteria. For small-enough structures, the obtained size-dependency (slope) of the free energy of binding suggest that, as long as only nonspecific interactions are involved, addition of a methylene-sized non-hydrogen atom to the ligand structure increases ΔG0 on average by about 1.5 kJ/mol, corresponding to an almost doubling of the binding affinity.",
keywords = "Binding affinity, Fluorination, Glucocorticoid, Molecular size, Structure-activity relationship",
author = "Peter Buchwald",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.steroids.2007.10.001",
language = "English",
volume = "73",
pages = "193--208",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Glucocorticoid receptor binding

T2 - A biphasic dependence on molecular size as revealed by the bilinear LinBiExp model

AU - Buchwald, Peter

PY - 2008/2/1

Y1 - 2008/2/1

N2 - For corticosteroids, receptor-binding affinity (RBA) at the glucocorticoid receptor (GR) is a major determinant of therapeutic potential. Here, the results of a comprehensive quantitative analysis of relative RBA (rRBA) data obtained from more than a hundred active structures are reported. Because of a clear biphasic size-dependence, the recently introduced linearized biexponential (LinBiExp) model provided very good fit: for steroids that satisfy the main binding criteria at the GR, it accounts for close to 80% of the variability in the free energy of binding ΔG0 (or log rRBA) data by using only two descriptors: calculated molecular volume and an indicator variable for the presence of 6α/9α-halogen or cyclic 16,17-acetal moieties. Accordingly, binding is strongest for corticosteroids close to an ideal size that is large enough to provide as large nonspecific (van der Waals-type) interactions as possible, but is not too large to have difficulty fitting due to size-limitations at the binding site. Binding affinity is dramatically increased by 6α- or 9α-halogenation or introduction of a cyclic 16,17-acetal moiety (in average, about 7-fold), but there is no significant increase after the first substitution. Known highly active glucocorticoids, such as betamethasone 17-monopropionate, fluticasone propionate, or mometasone furoate, indeed satisfy both of these criteria. For small-enough structures, the obtained size-dependency (slope) of the free energy of binding suggest that, as long as only nonspecific interactions are involved, addition of a methylene-sized non-hydrogen atom to the ligand structure increases ΔG0 on average by about 1.5 kJ/mol, corresponding to an almost doubling of the binding affinity.

AB - For corticosteroids, receptor-binding affinity (RBA) at the glucocorticoid receptor (GR) is a major determinant of therapeutic potential. Here, the results of a comprehensive quantitative analysis of relative RBA (rRBA) data obtained from more than a hundred active structures are reported. Because of a clear biphasic size-dependence, the recently introduced linearized biexponential (LinBiExp) model provided very good fit: for steroids that satisfy the main binding criteria at the GR, it accounts for close to 80% of the variability in the free energy of binding ΔG0 (or log rRBA) data by using only two descriptors: calculated molecular volume and an indicator variable for the presence of 6α/9α-halogen or cyclic 16,17-acetal moieties. Accordingly, binding is strongest for corticosteroids close to an ideal size that is large enough to provide as large nonspecific (van der Waals-type) interactions as possible, but is not too large to have difficulty fitting due to size-limitations at the binding site. Binding affinity is dramatically increased by 6α- or 9α-halogenation or introduction of a cyclic 16,17-acetal moiety (in average, about 7-fold), but there is no significant increase after the first substitution. Known highly active glucocorticoids, such as betamethasone 17-monopropionate, fluticasone propionate, or mometasone furoate, indeed satisfy both of these criteria. For small-enough structures, the obtained size-dependency (slope) of the free energy of binding suggest that, as long as only nonspecific interactions are involved, addition of a methylene-sized non-hydrogen atom to the ligand structure increases ΔG0 on average by about 1.5 kJ/mol, corresponding to an almost doubling of the binding affinity.

KW - Binding affinity

KW - Fluorination

KW - Glucocorticoid

KW - Molecular size

KW - Structure-activity relationship

UR - http://www.scopus.com/inward/record.url?scp=37649006828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37649006828&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2007.10.001

DO - 10.1016/j.steroids.2007.10.001

M3 - Article

C2 - 18022656

AN - SCOPUS:37649006828

VL - 73

SP - 193

EP - 208

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 2

ER -